2587 — HealthyWay Cashflow Statement
0.000.00%
- HK$3.33bn
- HK$3.07bn
- CNY1.56bn
Annual cashflow statement for HealthyWay, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -152 | -258 | -321 | -264 | 59.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 151 | 276 | 329 | 279 | 10.8 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.6 | -12 | -24.2 | 3.33 | -56.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 14.2 | 8.78 | 3.59 | 56.7 | 75 |
| Capital Expenditures | -0.445 | -16.4 | -39.1 | -76.2 | -34.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 7.99 | -4.69 | 1.36 | -5.47 | 9.31 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 7.54 | -21.1 | -37.7 | -81.7 | -25.5 |
| Financing Cash Flow Items | -2.26 | -3.19 | -4.37 | 163 | -7.53 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14.8 | 38 | 133 | 117 | -35.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.94 | 25.7 | 99 | 91.5 | 11.3 |